HNSCC, and particularly HPV-negative tumors, demonstrate genetic alterations leading to gene expression changes in protein methyltransferases and demethylases, with a significant body of preclinical evidence supporting the importance of this class of enzymes in the pathogenesis of this disease. This evidence concerns the gene MBD2 and head and neck squamous cell carcinoma.